EGFR and neoplasm: Icotinib treatment gradually and persistently inhibited EGFR, ERK, and Akt phosphorylation rather than downregulating protein expression in HCC827 cells, indicating that icotinib may suppress components of the MAPK and PI3K signaling pathways, thereby significantly inhibiting tumor cell growth and inducing apoptosis in sensitive cell lines.